US SB440 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Republican 3-0)
Status: Introduced on February 12 2019 - 25% progression
Action: 2019-06-28 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 129.
Text: Latest bill text (Introduced) [PDF]

Summary

PACED Act Preserving Access to Cost Effective Drugs Act This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings before the International Trade Commission. Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

PACED Act Preserving Access to Cost Effective Drugs Act

Sponsors


History

DateChamberAction
2019-06-28SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 129.
2019-06-28SenateCommittee on the Judiciary. Reported by Senator Graham with an amendment in the nature of a substitute. Without written report.
2019-06-27SenateCommittee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
2019-02-12SenateRead twice and referred to the Committee on the Judiciary.

Subjects


US Congress State Sources


Bill Comments

feedback